medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2018, Number 1

<< Back

Arch Med Fam 2018; 20 (1)

Atrial Fibrillation in the Geriatric Patient; Frequency, Associated Factors and Relationship with Cognitive and Functional Impairment

Márquez-Bouchán AL, Guatemala-Pineda F, González Pedraza-Avilés A

Language: Spanish
References: 18
Page: 35-40
PDF size: 142.45 Kb.


ABSTRACT

Objective: To determine the relationship between atrial fibrillation and cognitive impairment in geriatric patients attending a Family Medicine Clinic. Methods: descriptive and cross-sectional study. A geriatric medical history and an electrocardiogram were performed; Scales of cognitive (Mini mental) and functional impairment (Brody Lawton and Barthel Index) were applied. To contrast the variables, Mann-Whitney U and χ2 were used with a significance level of 0.05. Results: 213 patients were included. Their cognitive and physical functionality were determined, and the relationship between atrial fibrillation and both types of functionality was identified. Atrial fibrillation occurred in 7 patients (3.3%), cognitive impairment in 72 (33.8%) and 4 patients (1.9%) presented functional dependence. Conclusion: The existence of a relationship between atrial fibrillation and cognitive impairment in geriatric patients was demonstrated.


REFERENCES

  1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001; 285(18):2370–2375.

  2. Zoni-Berisso M, Filippi A, Landolina M et al. Frequency, patient characteristics, treatment strategies, and resource usage of atrial fibrillation (from the Italian Survey of Atrial Fibrillation Management [ISAF] study). Am J Cardiol. 2013; 111(5):705–711.

  3. Pulignano G, Del Sindaco D, Tinti MD, Tolone S, Minardi G, Lax A, Atrial fibrillation management in older heart failure patients: a complex clinical problem. Heart Int. 2016 Sep 22; 11(1):e41-e49. eCollection 2016 Jan-Dec.

  4. Zeki Al Hazzouri A, Haan MN, Neuhaus JM, Pletcher M. Et al. Cardiovascular risk score, cognitive decline, and dementia in older Mexican Americans: the role of sex and education. J Am Heart Assoc. 2013; 2:e004978.

  5. Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C. Et al. Prognosis with dementia in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000; 54: S16–S204.-

  6. Cao L, Pokorney SD, Hayden K, Welsh-Bohmer K, Newby K. Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke? J Am Heart Assoc. 2015; 4:1-10.

  7. - Marzona I, O’Donnell M, Teo K, Gao P, Anderson C. Et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies. CMAJ. 2012; 184:E329–E336.

  8. Hui DS, Morley JH, Mikolajczak PC, Lee R. Atrial fibrillation: A major risk factor for cognitive decline. Am Heart J 2015; 169 (4): 448-456.

  9. - Bruijn R, Bos MJ, Portegies M, Hofman A, Franco O. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Medicine.2015; 13:132.

  10. Custodio N, Wheelock A, Thumala D, Slachevsky A. Dementia in Latin America: Epidemiological Evidence and Implications for Public Policy. Front Aging Neurosci. 2017 Jul 13; 9: 221. doi: 10.3389/fnagi.2017.00221. eCollection 2017.

  11. Hsu NW, Tsao HM, Chen HS, Lo SS, Chen SA. Et al. Different Impacts of Atrial Fibrillation and Cardiac Premature Contractions on the Health-Related Quality of Life in Elderly People: The Yilan Study. Tohoku J. Exp. Med., 2016, 238; 75-83.

  12. Montes de Oca Sergio Luis, Albert Victorero Ariagna. Fibrilación auricular en la Unidad de Vigilancia Coronaria. Rev Ciencias Médicas [Internet]. 2013 Jun [citado 2017 Ago 23] ; 17( 3 ): 49-58. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561- 31942013000300006&lng=es.

  13. Ceornodolea AD, Bal R, Severens JL. Epidemiology and Management of Atrial Fibrillation and Stroke: Review of Data from Four European Countries. Stroke Res Treat. 2017; 2017:8593207. doi: 10.1155/2017/8593207. Epub 2017 May 28.

  14. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013 Sep; 34(35):2746-51. doi: 10.1093/eurheartj/eht280. Epub 2013 Jul 30.

  15. Li LH, Sheng CS, Hu BC, Huang QF, Zeng WF. The prevalence, incidence, management and risks of atrial fibrillation in an elderly Chinese population: a prospective study. BMC Cardiovascular Disorders. 2015; 15:31.

  16. Santangeli P, Di Biase L, Bai R, Mohanty S, Pump A, Et al. Atrial fibrillation and the risk of incident dementia: a meta-analysis. Heart Rhythm. 2012; 9:1761–1768.

  17. Douiri A, McKevitt C, Emmett ES, Rudd AG, Wolfe CD. Long-term effects of secondary prevention on cognitive function in stroke patients. Circulation. 2013; 128:1341–1348. 102.

  18. Choe WC, Passman RS, Brachmann J, Morillo CA, Sanna T. Et al. A Comparison of Atrial Fibrillation Monitoring Strategies After Cryptogenic Stroke (from the Cryptogenic Stroke and Underlying AF Trial). Am J Cardiol 2015; 116:889-893.




2020     |     www.medigraphic.com